Delivery Order SPE2DR25D1017-SPE2DR26F9AEV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Creon DR 36,000 Unit Capsules in units of 100s, with a contract value of $2,887.75. This non-set-aside, firm fixed-price delivery order is scheduled for completion by November 26, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Creon DR 24,000 unit capsules in quantities of 100s, with a ceiling value of $1,718.56. This is a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competitively awarded among qualified...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of 12,000 unit capsules of Creon DR 100s, with a ceiling value of $3,797.77. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, demonstrating AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $6,150.38. This competitively awarded, firm fixed-price delivery order is set to be completed by July 30, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Creon DR 36,000 unit capsules in quantities of 100 count units. This firm fixed-price delivery order carries a ceiling value of $2,223.33 and is scheduled for completion by November 26, 2025. The contract was competitively awarded with no set-aside designation, and performance will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Creon DR 24,000 unit capsules in quantities of 100 count, with a contract ceiling value of $4,972.54. This is a firm fixed price delivery order with an ultimate completion date of November 25, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of 36,000 unit capsules of Creon DR 100s with a ceiling value of $58,274.04. This firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation and represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Creon DR 24,000 unit capsules in quantities of 100s, with a ceiling value of $2,781.34. This is a firm fixed price delivery order with an ultimate completion date of August 7, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for 36,000 units of Creon DR 100s capsules, valued at $2,704.53. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of December 12, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $9,788.44. This is a firm fixed price delivery order with an ultimate completion date of October 30, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award was made without a set-aside designation, indicating that AmerisourceBergen competed for this order on an open basis. This...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9AEVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Creon DR 24,000 unit capsules in 100-count bottles, with a ceiling value of $2,208.22. This is a firm fixed-price delivery order with an ultimate completion date of November 25, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The Creon DR delivery reflects the company's ongoing role in providing pharmaceutical products across multiple therapeutic domains to the Defense Health Agency and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 11/23/25 |